Adoption of FTE Contracts in R&D Outsourcing: Present and Future

author

By: Beroe Inc. --

30 June, 2014

Adoption of FTE Contracts in R&D Outsourcing: Present and Future
WHITEPAPER

In today?s competitive environment, pharma companies need to focus on their core competencies in Research & Development (R&D). Pharma companies are focusing on increasingly outsourcing of R&D activities to contract research organizations (CROs) as a way to boost pharma R&D pipelines productivity e.g. global drug discovery market for outsourced was up 15% from last year. Pharma is engaging with CROs on long term basis strategically and looking for outsourcing high volume of work throughout the drug discovery and development.




x

COVID-19: Assess impact on your suppliers and ensure business continuity with Beroe’s WIRE
(World Instant Risk Exposure)